Prosecution Insights
Last updated: April 19, 2026

Examiner: ANDERSON-FEARS, KEENAN NEIL

Tech Center 1600 • Art Units: 1687

This examiner grants 6% of resolved cases

Performance Statistics

6.3%
Allow Rate
-53.7% vs TC avg
61
Total Applications
+50.0%
Interview Lift
1870
Avg Prosecution Days
Based on 16 resolved cases, 2023–2026

Rejection Statute Breakdown

32.6%
§101 Eligibility
12.7%
§102 Novelty
33.2%
§103 Obviousness
15.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17459743 COMPUTATIONAL DETECTION OF COPY NUMBER VARIATION AT A LOCUS IN THE ABSENCE OF DIRECT MEASUREMENT OF THE LOCUS Final Rejection GUARDANT HEALTH, INC.
18225098 COMPUTING AFFINITY FOR PROTEIN-PROTEIN INTERACTION Non-Final OA ImmunityBio, Inc.
17518953 METHOD AND APPARATUS FOR DETECTING MOLECULE BINDING SITE, ELECTRONIC DEVICE, AND STORAGE MEDIUM Non-Final OA Tencent Technology (Shenzhen) Company Limited
17521023 TRAIT PREDICTION MODEL GENERATION APPARATUS, TRAIT PREDICTION APPARATUS, AND METHOD FOR GENERATING A TRAIT PREDICTION MODEL Final Rejection KABUSHIKI KAISHA TOSHIBA
17548342 PROTEIN COMPLEX STRUCTURE PREDICTION FROM CRYO-ELECTRON MICROSCOPY (CRYO-EM) DENSITY MAPS Non-Final OA University of Washington
17344510 COMPUTER SYSTEMS AND METHODS FOR MACHINE-LEARNING BASED TREATMENT MODELING FOR ONCOLOGY BASED ON INCONSISTENT RAS BIOMARKER DETECTION DATA RECORDS Non-Final OA Optum, Inc.
17565282 METHOD FOR TRAINING COMPOUND PROPERTY PREDICTION MODEL AND METHOD FOR PREDICTING COMPOUND PROPERTY Final Rejection Beijing Baidu Netcom Science Technology Co., Ltd.
17653077 SYSTEM FOR CONTROL AND ANALYSIS OF GAS FERMENTATION PROCESSES Non-Final OA LanzaTech, Inc.
17805511 COMPUTING DEVICE WITH IMPROVED USER INTERFACE FOR INTERPRETING AND VISUALIZING DATA Non-Final OA Roche Sequencing Solutions, Inc.
17312107 PREDICTING AFFINITY USING STRUCTURAL AND PHYSICAL MODELING Final Rejection University of Notre Dame du Lac
17464061 BIOMARKERS AND METHODS FOR MEASURING AND MONITORING AXIAL SPONDYLOARTHRITIS ACTIVITY Non-Final OA Laboratory Corporation of America Holdings
17552861 COMPUTER SYSTEM AND METHOD THEREOF Final Rejection KYOTO UNIVERSITY
17439374 SYSTEMS AND METHODS TO CLASSIFY ANTIBODIES Final Rejection ETH ZURICH
17621200 METHODS FOR GUIDING DIRECT DELIVERY OF DRUGS AND/OR ENERGY TO LESIONS USING COMPUTATIONAL MODELING Non-Final OA University of Vermont and State Agricultural College
17570416 METHOD OF TRAINING PREDICTION MODEL FOR DETERMINING MOLECULAR BINDING FORCE Final Rejection Baidu.com Times Technology (Beijing) Co., Ltd.
17640771 METHOD FOR CLASSIFYING MONITORING RESULTS FROM AN ANALYTICAL SENSOR SYSTEM ARRANGED TO MONITOR MOLECULAR INTERACTIONS Final Rejection Cytiva Sweden AB
17616244 SYSTEMS AND METHODS FOR DETERMINING SEQUENCE Non-Final OA XGenomes Corp.
17615989 METHOD FOR DETERMINING AT A CURRENT TIME POINT A PRESERVATION STATE OF ONE PRODUCT AND COMPUTER SYSTEM FOR CARRYING OUT SAID METHOD Non-Final OA Sanofi Pasteur
17697301 SYSTEMS AND METHODS FOR GENERATING GRAPH REFERENCES Non-Final OA Seven Bridges Genomics Inc.
17708261 SYSTEMS AND METHODS FOR SIMULATING IMMUNE RESPONSE Non-Final OA University of Pennsylvania
17698884 PRECISION MEDICINE PORTAL FOR HUMAN DISEASES Non-Final OA Genome International Corporation
17676758 BRAIN STIMULATION SIMULATION SYSTEM AND METHOD ACCORDING TO PRESET GUIDE SYSTEM USING ANONYMIZED DATA-BASED EXTERNAL SERVER Final Rejection NEUROPHET Inc.
17544947 EARLY DETECTION AND PREDICTION METHOD OF PAN-CANCER Non-Final OA Pharus Taiwan, Inc.
17369499 SYSTEMS AND METHODS FOR CLASSIFYING, PRIORITIZING AND INTERPRETING GENETIC VARIANTS AND THERAPIES USING A DEEP NEURAL NETWORK Non-Final OA Deep Genomics Incorporated
17367498 Multiplex PCR Kit for identifying human genotype profile using new combination of mini STRs and method for identifying human genotype profile using the same Final Rejection Republic of Korea (National Forensic Service Director Ministry of Interior and Safety)

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month